Guindo Chirfi

MRK CMO Guindo Chirfi sold 10,000 shares at $121.46; holds 60,615 post-transaction with 2 prior MRK sells in 4 days.

Guindo Chirfi, Chief Marketing Officer at Merck & Co., Inc., executed a sale of 10,000 shares on 2026-02-12 at $121.46 per share, totaling $1,214,562.00, reducing his holdings from 70,615 shares to 60,615 shares. This transaction is the third MRK sale within a 7-day window (prior sells on 2026-02-09 and 2026-02-05), suggesting concentrated portfolio activity at the CMO level over a brief period. The transaction occurred near the 52-week high of $121.93, with the stock having appreciated 10.1% over 30 days and 28.3% over 90 days. Merck's fundamentals remain solid (revenue $17.3B, net income $5.8B, annual growth +6.7%, P/E 15.55), and the current price of $119.24 sits only 2.2% below the 52-week high, suggesting no obvious deterioration in the company's market standing at the time of sale. The clustering of three insider sales in rapid succession warrants observation of whether this reflects a structured divestment plan or discretionary positioning decisions.

Merck CMO Guindo Chirfi sold 10,000 shares at $118.41 on 2026-02-09, reducing stake to 70,615 shares (-12.4%)

Guindo Chirfi, Chief Marketing Officer of Merck & Co., Inc., executed a sale of 10,000 shares at $118.41 on 2026-02-09 for a total value of $1,184,101.00, reducing his holdings from 80,615 to 70,615 shares. The sale occurred near Merck's 52-week high of $121.93 (within 3.5% of peak), and follows a strong 90-day appreciation of +29.4%, suggesting the asset has appreciated significantly during his holding period. His cross-ticker track record shows only 1 prior open-market sale across all tickers, and the outcome of his same-ticker trade on 2026-02-05 remains unmeasurable at this stage. The transaction's modest scale relative to his total holdings and the absence of a discernible pattern in his sales history make this a routine portfolio adjustment for the organization's top marketing executive.

CMO Guindo Chirfi sold 20,000 MRK shares at $121.88 for $2.4M, reducing holdings by 19.9%

Guindo Chirfi, Chief Marketing Officer of Merck & Co., sold 20,000 shares (20.0K shares) for $2,437,676.00 ($2.4M) on 2026-02-05 at $121.88, reducing his post-transaction holdings to 80,615 shares (80.6K shares) from a pre-transaction level of 100,615 shares (100.6K shares). The sale occurred while MRK was trading near its 52-week high of $121.93, with the stock up 12.3% over the prior 30 days and 41.3% over 90 days, suggesting a period of strong recent performance. Merck's fundamentals remain solid, with trailing quarterly revenue of $17,276,000,000.00 ($17.3B), net income of $5,785,000,000.00 ($5.8B), a P/E of 15.90, and a market cap of $302,633,007,814.48 ($302.6B). The 19.9% reduction in Chirfi's position represents a material but not complete liquidation of his holdings, occurring within the context of broad-based stock strength rather than a deteriorating operating environment.